Medāna Brings Its Risk-Based AI Platform to Poland, Advancing Patient-Centered Healthcare Across Europe

The global company, based in Lisbon, is beginning its expansion into Poland with collaborative and innovative risk-based models

LISBON, Portugal, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Poland is about to welcome one of the most disruptive innovations in digital health. Medāna (www.medana.ai), the global company founded by Dr. Tal Patalon, today announced its strategic entry into the Polish healthcare market as part of its broader European expansion.

Medāna bridges the gap between AI’s promise and its limited real-world implementation. The company has developed a state-of-the-art AI infrastructure that integrates seamlessly into existing healthcare systems, including hospitals, clinics, laboratories, insurance providers and pharmaceutical companies. Its platform leverages advanced multi-omics and genetic data to validate algorithms, generate health scoring, and pioneer risk-based medicine. By harmonizing diverse healthcare data, Medāna transforms organizational workflows into a dynamic, proactive and AI-ready environment.

The platform reduces delays in treatment and empowers both patients and healthcare providers by generating insights and risk profiles - improving outcomes, optimizing care pathways, and identifying the next best step for individuals and populations alike.

Medāna’s platform has been successfully validated within a leading healthcare organization serving 2.8 million members, where it has proven its unique ability to integrate genetic and clinical data to deliver measurable real-world outcomes. Additional validations are currently underway across Europe. This demonstrates the platform’s power to drive earlier risk detection and smarter population health management, setting a new benchmark for predictive and precision medicine.

“Our approach accelerates the shift away from the outdated one-size-fits-all paradigm toward preventive and truly personalized care. At Medāna, we believe everyone should be empowered with clarity to take the right action, at the right time, for the best possible care journey. Poland has a strong knowledge infrastructure and a growing ambition to lead in deep tech and digital innovation. We believe the Polish ecosystem is ready to scale bold ideas into global solutions - and we want to be among the leaders in this collective effort to turn vision into action”, said Dr. Tal Patalon, Medāna’s Founder & CEO.

Dr. Patalon (MD, LLB, MBA), an active clinician specializing in family and emergency medicine, was recognized by Nature magazine as one of the global changemakers shaping the future of medicine. She also leads R&D at Maccabi Healthcare Services and contributes regularly to Forbes.com on health innovation.

Following successful market entry in Portugal, Spain, Isreal and the Netherlands, Medāna is now initiating collaborations with healthcare organizations in Poland. Beyond technology, the company also brings economic value through the creation of skilled jobs and by fostering growth across the healthcare ecosystem.

Medāna invites Polish health leaders to join its vision of a smarter, more sustainable, and patient-centered healthcare future - delivering personalized, proactive care and transforming the way medicine is practiced today.

Contact info:

Ricardo Rodrigues

+351969523802

RR@PRESSMEDIAONLINE.COM

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c4dfb313-a3b4-4288-b976-15cb783b6a77

Dr. Tal Patalon

Medāna Founder & CEO

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.